Kristin Roseth Aass

Researcher in molecular medicine, focusing on Multiple myeloma

[NTNU Klinisk og Molekylær Medisin @NTNUikom]

Activation of TLRs in an inflamed or infectious bone marrow microenvironment may lead to pro-tumorigenic IL-32 expression in multiple myeloma https://t.co/KTt3k9UMMS @ThereseStandal @RosethAass @MjelleLab @KristineMisund @Hamartinka @TonjeNedal

[ThereseS @ThereseStandal]

Why is IL-32 expression in cancer cells bad for multiple myeloma patients? Kristin's PhD work is finally out! @RosethAass @tobiasslordahl @HealthNTNU Read the full story @iScience_CP
https://t.co/YOcYcl9jk8